Your browser doesn't support javascript.
loading
Correction: Anti-CD5 CAR-T cells with a tEGFR safety switch exhibit potent toxicity control.
Lin, Haolong; Cheng, Jiali; Zhu, Li; Zeng, Yuhao; Dai, Zhenyu; Zhang, Yicheng; Zhu, Xiaojian; Mu, Wei.
Affiliation
  • Lin H; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, 430030, China.
  • Cheng J; Immunotherapy Research Center for Hematologic Diseases of Hubei Province, Wuhan, Hubei, 430030, China.
  • Zhu L; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, 430030, China.
  • Zeng Y; Immunotherapy Research Center for Hematologic Diseases of Hubei Province, Wuhan, Hubei, 430030, China.
  • Dai Z; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, 430030, China.
  • Zhang Y; Immunotherapy Research Center for Hematologic Diseases of Hubei Province, Wuhan, Hubei, 430030, China.
  • Zhu X; Department of Internal Medicine, Cleveland Clinic, Akron General, Akron, OH, USA.
  • Mu W; Division of Blood and Marrow Transplantation and Cellular Therapy, Department of Medicine, Stanford University, Stanford, CA, USA.
Blood Cancer J ; 14(1): 123, 2024 Jul 24.
Article in En | MEDLINE | ID: mdl-39048546
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Blood Cancer J Year: 2024 Document type: Article Affiliation country: China Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Blood Cancer J Year: 2024 Document type: Article Affiliation country: China Country of publication: United States